Making SMA Newborn Screening a Reality: Collaborating with the Patient Advocacy Community
Each year, roughly 12,500 newborns in the U.S., or one out of every 300 infants, are diagnosed with one of the 29 conditions that every newborn is screened for shortly after delivery. Ranging from cystic fibrosis to Sickle cell anemia, the conditions often require immediate and intensive medical intervention. This list of conditions includes spinal muscular atrophy (SMA), which until earlier this year, was excluded from the Recommended Universal Screening Panel (RUSP), the expert-app
Read more »